South Carolina Sci-Tech Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on South Carolina Sci-Tech Wire.

Press releases published on October 22, 2026

5 hours ago

Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4

Indeterminate GlobeNewswire

5 hours ago

Korro Reports Best-in-Class Preclinical Data for KRRO-111 Demonstrating Potential to Benefit Lung and Liver Manifestations of Alpha-1 Antitrypsin Deficiency

Indeterminate GlobeNewswire

5 hours ago

Sagimet Biosciences Announces First Patient Dosed in AURORA Phase 3 U.S. Clinical Trial of Denifanstat for Moderate to Severe Acne

Indeterminate GlobeNewswire

5 hours ago

Agility Robotics Expands NVIDIA Collaboration as It Prepares Digit 5 for Commercial Scale

Indeterminate GlobeNewswire

5 hours ago

Palomino Laboratories Inc. Receives Its First Commercial Purchase Order from a Hyperscaler Customer For GaN MicroLED Communication Chips Supporting AI Optical Interconnects

Indeterminate GlobeNewswire

5 hours ago

Medicenna to Present Preclinical Data on Its CD122 Superantagonist MDNA209 at The Promises of Treg and Interleukin-2 Therapies Conference

Indeterminate GlobeNewswire

5 hours ago

Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs

Indeterminate GlobeNewswire

5 hours ago

Schneider Electric, NVIDIA & HPE announce strategic collaboration to accelerate Physical AI for Process Industries

Indeterminate GlobeNewswire

5 hours ago

Roper Technologies Announces Third Quarter Financial Results

Indeterminate GlobeNewswire

5 hours ago

Evergrow Launches Mobile App With a Bite-Sized “Smart Scrolling” Approach to Learning

Indeterminate GlobeNewswire

5 hours ago

BioNTech treibt klinische Phase-3-Studie zu Pumitamig mit Gileads gegen TROP2-gerichtetem Antikörper-Wirkstoff-Konjugat Sacituzumab Govitecan bei Dreifach-Negativem Brustkrebs voran

Indeterminate GlobeNewswire

5 hours ago

BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer

Indeterminate GlobeNewswire

5 hours ago

WEL Companies Streamlines Freight Brokerage and Carrier Workflows with Integrated Descartes and CARRIER1 Solutions

Indeterminate GlobeNewswire

5 hours ago

NewsGenie Demonstrates the Future of Journalism with BalVoi, a 100% AI-Automated Newsroom

Indeterminate GlobeNewswire

6 hours ago

Istios Health Expands Clinical Research Network into Texas Through Kidney Care Associates Partnership

Indeterminate GlobeNewswire

6 hours ago

Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

6 hours ago

Cognition Therapeutics Announces Alignment with FDA on Pivotal Phase 3 Trial of Zervimesine (CT1812) in Dementia with Lewy Bodies

Indeterminate GlobeNewswire

6 hours ago

Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection

Indeterminate GlobeNewswire

7 hours ago

EC-Council Expands Technology Risk Capabilities Through Acquisition of Cyber Insurance Academy

Indeterminate GlobeNewswire

7 hours ago

Virtune announces harmonization of rebalancing schedules for selected index ETPs

Indeterminate GlobeNewswire